ARDELYX, INC. Proceeds from Sale of Short-term Investments
ARDELYX, INC. (ARDX) reported Proceeds from Sale of Short-term Investments of $2.00 million for the 12-month period ending 2019-12-31, per its 10-K filed 2020-03-06.
Discontinued › Cash Flow › Investing Activities
us-gaap:ProceedsFromSaleOfShortTermInvestments · last filed 2020-03-06
- ARDELYX, INC. proceeds from sale of short-term investments for the quarter ending 2017-06-30 was $0.00.
- ARDELYX, INC. proceeds from sale of short-term investments for the quarter ending 2017-03-31 was $10.48M.
- ARDELYX, INC. proceeds from sale of short-term investments for fiscal 2019 was $2.00M, a 135.29% increase from fiscal 2018.
- ARDELYX, INC. proceeds from sale of short-term investments for fiscal 2018 was $850.00K, a 95.27% decline from fiscal 2017.
- ARDELYX, INC. proceeds from sale of short-term investments for fiscal 2017 was $17.96M, a 136.28% increase from fiscal 2016.
- ARDELYX, INC. proceeds from sale of short-term investments for fiscal 2016 was $7.60M.
| Period end | Proceeds from Sale of Short-term Investments 3 month | Proceeds from Sale of Short-term Investments 6 month | Proceeds from Sale of Short-term Investments 12 month |
|---|---|---|---|
| 2019-12-31 | $2.00M 10-K · filed 2020-03-06 | ||
| 2018-12-31 | $850.00K 10-K · filed 2020-03-06 | ||
| 2017-12-31 | $17.96M 10-K · filed 2020-03-06 | ||
| 2017-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-09 | $10.48M 10-Q · filed 2017-08-09 | |
| 2017-03-31 | $10.48M 10-Q · filed 2017-05-05 | ||
| 2016-12-31 | $7.60M 10-K · filed 2017-02-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Avalo Therapeutics, Inc. (AVTX) | United States | $0.842B | -9.74 |
| Immix Biopharma, Inc. (IMMX) | United States | $0.837B | -18.44 |
| Cryoport, Inc. (CYRX) | United States | $0.881B | -21.29 |
| Theravance Biopharma, Inc. (TBPH) | $0.885B | 16.40 | |
| Obsidian Therapeutics, Inc. (OBX) | United States | $0.829B | |
| LEXICON PHARMACEUTICALS, INC. (LXRX) | United States | $0.823B | -17.48 |
| RIGEL PHARMACEUTICALS INC (RIGL) | United States | $0.893B | 2.25 |
| GYRE THERAPEUTICS, INC. (GYRE) | United States | $0.818B | -24.71 |
| Apnimed, Inc. (APMD) | United States | $0.899B | |
| GERON CORP (GERN) | United States | $0.803B | -12.14 |